Helio AI | $1,000,000 | (Nov 27, 2025)
Procure Ai | $13,000,000 | (Nov 27, 2025)
Overstory | $43,000,000 | (Nov 27, 2025)
RyboDyn Inc.
United States
- San Diego, California
- 10/01/2025
- Pre-Seed
- $4,000,000
RyboDyn, Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific targets that will impact the treatment of cancer and autoimmune diseases by driving a new wave of targeted therapeutics. Our "targets-to-assets" therapeutics development program is supported by a scalable, in-house platform for lead discovery and optimization. We aim to deliver first-in-class assets that recognize these targets for treating solid tumors and diseases lacking effective treatment options.
- Industry Biotechnology Research
- Website https://www.rybodyn.com/
- LinkedIn https://www.linkedin.com/company/rybodyn/
Related People
Imad Ajjawi, PhD, MBACo Founder
United States -
San Diego, California
Biotechnology entrepreneur passionate about revolutionizing the biotech industry. Founded Denovium, an AI biotech company for protein discovery and design. Acquired by Absci. IPO less than a year later at a $1.5B pre-money valuation. Secured >$100M funds via strategic partnerships, M&A and VCs. Authored >25 patents and peer-reviewed manuscripts (see Google Scholar). Featured in WIRED, Forbes, Bloomberg, NPR, and other media outlets.
Global Work AI | $2,400,000 | (Nov 27, 2025)
SubImage (YC W25) | $4,200,000 | (Nov 27, 2025)
AUGMENTT | $18,000,000 | (Nov 27, 2025)
EcoG | $18,573,280 | (Nov 27, 2025)
Parallax Worlds | $4,900,000 | (Nov 27, 2025)
CoPlane | $14,000,000 | (Nov 27, 2025)
The Intelligent Search Company (TISC) | $2,100,000 | (Nov 27, 2025)
Redrob | $10,000,000 | (Nov 25, 2025)
Relixir | $2,000,000 | (Nov 25, 2025)